Raymond James Trust N.A. Corcept Therapeutics Inc Transaction History
Raymond James Trust N.A.
- $4.22 Billion
- Q2 2024
A detailed history of Raymond James Trust N.A. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Raymond James Trust N.A. holds 18,000 shares of CORT stock, worth $714,780. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,000
Previous 18,000
-0.0%
Holding current value
$714,780
Previous $453,000
28.92%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding CORT
# of Institutions
311Shares Held
88.3MCall Options Held
1.07MPut Options Held
973K-
Black Rock Inc. New York, NY16.5MShares$657 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.55MShares$379 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.24MShares$327 Million11.51% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.91MShares$274 Million0.4% of portfolio
-
Parallel Advisors, LLC3.82MShares$152 Million3.2% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $4.25B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...